Tagged 'Zantac'

The Journal of the American Medical Association (JAMA) has published a new study on Zantac. It may impact ongoing Zantac lawsuits. The popular heartburn […]

In July 2018, several forms of valsartan (a heartburn drug) were recalled. Test results revealed a cancer-causing material in the drug, triggering the recall. […]

Plaintiffs in Zantac cancer litigation recently experienced a setback. A federal judge threw out a number of claims filed under states' laws. According to […]

One of the many difficulties posed by this past year has been the number of drug recalls. In this period, many of these recalled […]

Nitrosamines are impurities found in some cured meats, vegetables and medications. These impurities could cause cancer if consumed in certain quantities over a long […]

NDMA (n-nitrosodimethylamine) is the probable human carcinogen behind a number of recent drug recalls. As of July 2020, NDMA has been found in blood […]

Zantac is a brand name heartburn medication previously available in over-the-counter (OTC) and prescription forms. Before the recall, Zantac was commonly sold as generic […]

Roughly six months ago, drug manufacturers began recalling Zantac (ranitidine) heartburn medications. This month, the U.S. Food and Drug Administration (FDA) requested all Zantac […]

This week's Legal Look covers coronavirus-related changes to Zantac and Zofran multidistrict litigation (MDL). It also touches on a recent suggestion that certain blood […]

Recently, contamination triggered widespread recalls of Zantac heartburn medication. As a result, the drug's manufacturers now face a growing number of legal and financial […]